- Home
- Software Solutions
- Resources
- Corporate
Thallion Pharmaceuticals Inc.
Thallion Pharmaceuticals Inc. Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Shiga Toxin Producing Bacterial Infection | >cαStx1/cαStx2 >Placebo | Phase_II | Study of Chimeric Monoclo... | NCT01252199 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Tumors Glioma Colorectal Cancer Lung Cancer Breast Cancer Ovarian Cancer Pancreatic Cancer Prostate Cancer | >ECO-4601 | Phase_I | A Phase I Study of ECO-46... | NCT00338026 |
| Complete | Melanoma | >TLN-232 | Phase_II | Efficacy Study of TLN-232... | NCT00735332 |
| Terminated | Glioblastoma Multiforme | >TLN-4601 | Phase_II | Efficacy Study of TLN-460... | NCT00730262 |
| Completed | Carcinoma, Renal Cell | >CAP-232 | Phase_II | Phase II Study of CAP-232... | NCT00422786 |